Identification of a novel autoantibody directed against small ubiquitin‐like modifier activating enzyme in dermatomyositis

Abstract

These findings reveal previously uncharacterized autoantibodies directed against a protein involved in posttranslational modification, the SUMO activating enzyme, in 2 patients with DM who had similar clinical features, including severe skin disease and interstitial pneumonia.